Companies / Tyra Biosciences, Inc. / Activity
Activity — Tyra Biosciences, Inc.
16 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 26, 2026 | Kaplan Gilla Director | Other | Common Stock | $2.01M | -53K -65.32% | 28,231 0.05% of shares | low |
| Mar 25, 2026 | Kaplan Gilla Director | Sell | Common Stock | $528.5K | -14K -33.61% | 28,231 0.05% of shares | medium |
| Jan 12, 2026 | Bensen Daniel Executive | Sell | Common Stock | $198.6K | -7K -4.28% | 155,998 0.26% of shares | medium |
| Feb 12, 2026 | Bensen Daniel Executive | Sell | Common Stock | $195.9K | -6K -3.84% | 146,981 0.25% of shares | medium |
| Mar 26, 2026 | Kaplan Gilla Director | Exercise | Common Stock | $119.6K | -53K -39.51% | 81,403 0.14% of shares | low |
| Feb 12, 2026 | Bensen Daniel Executive | Sell | Common Stock | $67.0K | -2K -1.37% | 152,853 0.26% of shares | low |
| Mar 25, 2026 | Kaplan Gilla Director | Exercise | Common Stock | $32.2K | +14K +50.64% | 42,526 0.07% of shares | low |
| Jan 12, 2026 | Bensen Daniel Executive | Sell | Common Stock | $29.6K | -1K -0.65% | 154,981 0.26% of shares | low |
| Mar 13, 2026 | Todd Harris CEO | Grant | Common Stock | $13.4K | +1K +0.11% | 1,358,631 2.28% of shares | low |
| Mar 13, 2026 | Fuhrman Alan Executive | Grant | Common Stock | $12.6K | +1K +9.30% | 16,164 0.03% of shares | low |
| May 5, 2026 | Fuhrman Alan Executive | Grant | Common Stock | $0 | +20K +123.73% | 36,164 0.06% of shares | low |
| May 28, 2026 | RA Capital Management, L.P. Director | Grant | Stock Option (Right to Buy) | — | +13K | 13,160 0.02% of shares | low |
| May 5, 2026 | Fuhrman Alan Executive | Grant | Stock Option (Right to Buy) | — | +67K | 67,000 0.11% of shares | low |
| May 28, 2026 | More Robert J Director | Grant | Stock Option (Right to Buy) | — | +13K | 13,160 0.02% of shares | low |
| Mar 26, 2026 | Kaplan Gilla Director | Exercise | Stock Option (Right to Buy) | — | -53K -100.00% | 0 0.00% of shares | low |
| Mar 25, 2026 | Kaplan Gilla Director | Exercise | Stock Option (Right to Buy) | — | -14K -21.19% | 53,172 0.09% of shares | low |